PUBLISHER: Orion Market Research | PRODUCT CODE: 1064708
PUBLISHER: Orion Market Research | PRODUCT CODE: 1064708
Global Orthopedic Hyaluronic Acid Market Size, Share & Trends Analysis Report, By Product (Single-Injection, Three-Injection, Five-Injection), By Application (Knee, Hip, Ankle, and Others)Forecast (2021-2027)
The global orthopedic hyaluronic acid market is anticipated to grow at a considerable CAGR during the forecast period. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan which is dispersed throughout the body in epithelial, connective tissues, and neural tissues. Mounting ageing population that are more prone to wide range of chronic diseases such as osteoarthritis, kidney, cancer and many more diseases and thus creates scope for the market growth. In addition, growing obesity across the globe is also a key reason for the development of orthopedic hyaluronic acid supplement as obese patients are also likely to undergo joint problems due to overweight.
The global orthopedic hyaluronic acid market is segmented based on product and application. On the basis of product, the market is sub-segmented into single-injection, three-injection, five-injection. Based on application, the market is sub-segmented into knee, hip, ankle, and others.
Geographically, the global orthopedic hyaluronic acid market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.
Some of the companies operating in the global orthopedic hyaluronic acid market include Allergan, Inc, Anika Therapeutics, F. Hoffmann-La Roche AG, Ferring Pharmaceuticals Co., Galderma S.A., Salix Pharmaceuticals Inc., Sanofi AG., and others.
Market Segmentation
The Report Covers